1 in 10 people worldwide—approximately 805 million individuals—suffer from kidney disease. Alarmingly, most of them remain unaware of their condition till very late into the disease. This is because the kidneys lack pain sensors, meaning there are no clear warning signs. As a result, kidney disease is typically detectable only through lab testing, often requiring multiple follow-ups for a definitive diagnosis which often comes too late with drastic changes to the life of a patient. NewGen Health is revolutionizing rapid and early detection with an accessible urine-based screening solution using novel biomarkers. Pairing our hardware with software tools, we can assist clinicians in monitoring their patients and making it easier to optimize dosing to protect kidney health and improve patient outcomes.